Search Drug By Letter : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

YTRACIS

Package:
VIAL: 1 x 2 ml.
Dosage:
To be used only with Zevalin. See literature.
Prescribing Restrictions:  None


Indications:
To be used only for the radiolabelling of carrier molecules which have been specifically developed and authorized for radiolabelling with Zevalin. Radiopharmaceutical precursor - Not intended for direct application to patients.
Contra-Indications:
Do not administer directly to the patient. Hypersensitivity to the Yttrium (⁹⁰Y) chloride or to any of the excipients. Established or suspected pregnancy or when pregnancy has not been excluded.
Special Precautions:
The content of the vial is not to be administered directly to the patient but must be used for the radiolabelling of Zevalin. See literature.
Side Effects:
Possible side effects will be dependent on the specific medicinal product being used. See prescribing information of the medicinal product to be radiolabelled. The radiation dose resulting from therapeutic exposure may result in higher incidence of cancer and mutations. See literature.
Drug Interactions:
See literature.